Inflammatory bowel disease, azathioprine and skin cancer: Case report and literature review

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 2, 2001, Pages 193-194

  Austin, Andrew S ^a   Spiller, Robin C ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Azathioprine; Inflammatory bowel disease; Keywords; Skin cancer

Indexed keywords

AZATHIOPRINE;

ADULT; ARTICLE; CANCER RISK; CASE REPORT; CAUCASIAN; ENTERITIS; FEMALE; HUMAN; IMMUNE DEFICIENCY; PRIORITY JOURNAL; SKIN CANCER; SUN EXPOSURE;

ADULT; AZATHIOPRINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; SKIN NEOPLASMS; SUNLIGHT;

EID: 0035131123     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200102000-00017     Document Type: Article

References (15)

1. Ness AR, Frankel SJ, Gunnell DJ, Smith GD. Are we really dying for a tan? Br Med J 1999; 319: 114 -116.
2. Walder BK, Robertson MR, Jeremy D. Skin cancer and immunosuppression. Lancet 1971; 2: 1282 -1283.
3. Kinlen LJ, Sheil AG, Peto J, Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J 1979; 2: 1461 -1466.
4. Gaya SB, Rees AJ, Lechler RI, Williams G, Mason PD. Malignant disease in patients with long-term renal transplants. Transplantation 1995; 59: 1705 -1709.
5. Glover MT, Deeks JJ, Raftery MJ, Cunningham J, Leigh IM. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients [Letter]. Lancet 1997; 349: 398. 398.
6. Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O. et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40 (2 part 1): 177 -186.
7. Frezza EE, Fung JJ, van Thiel DH. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 1997; 44: 1172 -1181.
8. Bouwes Bavinck JN, de Boer A, Vermeer B. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129: 242 -249.
9. Veness MJ. Cardiac transplant-related cutaneous malignancies in an Australian recipient: immunosuppression, friend or foe? Clin Oncol 1998; 10: 194 -197.
10. Dalton A, Curtis D, Harrington CI. Synergistic effects of azathioprine and ultraviolet light detected by sister chromatid exchange analysis. Cancer Genet Cytogenet 1990; 45: 93 -99.
11. Amato MP, Pracucci G, Ponziani G, Siracusa G, Fratiglioni L, Amaducci L. Long-term safety of azathioprine therapy in multiple sclerosis. Neurology 1993; 43: 831 -833.
12. Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985; 78: 44 -49.
13. Mellemkjaer L, Olsen JH, Frisch M, Johanssen C, Gridley G. Cancer in patients with ulcerative colitis. Int J Cancer 1995; 60: 330 -333.
14. Ekbom A, Helmick C, Zack M, Adami H-O. Extracolonic malignancies in inflammatory bowel disease. Cancer 1991; 67: 2015 -2019.
15. Bouhnik Y, Lemann M, Mary JY, Scemana G, Tai2 R, Matuchansky C. et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mescaptoparine. Lancet 1996; 347: 215 -219.